ERBB2 and breast cancer: Interestingly, in the ECT-treated breast cancer cohort, CIN70 scores were greatest in triple-negative breast cancers (TNBC) relative to ER/PR+ and HER2+ breast cancers (Supplementary Fig. 3a), consistent with evidence for increased CIN in TNBCs8.